Found: 26
Select item for more details and to access through your institution.
Observational Study Comparing Efficacy and Safety between Neoadjuvant Concurrent Chemoradiotherapy and Chemotherapy for Patients with Unresectable Locally Advanced or Metastatic Gastric Cancer.
- Published in:
- Journal of Oncology, 2020, p. 1, doi. 10.1155/2020/6931317
- By:
- Publication type:
- Article
Low-Molecular-Weight Fucoidan as Complementary Therapy of Fluoropyrimidine-Based Chemotherapy in Colorectal Cancer.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 15, p. 8041, doi. 10.3390/ijms22158041
- By:
- Publication type:
- Article
Pretreatment Neutrophil-to-Lymphocyte Ratio Associated with Tumor Recurrence and Survival in Patients Achieving a Pathological Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4589, doi. 10.3390/cancers13184589
- By:
- Publication type:
- Article
Surgical Efficacy and Safety of Patients with Locally Advanced Gastric Cancer following Neoadjuvant Concurrent Chemoradiotherapy and Chemotherapy.
- Published in:
- Journal of Oncology, 2022, p. 1, doi. 10.1155/2022/3719241
- By:
- Publication type:
- Article
UGT1A1 Polymorphism for Irinotecan Dose Escalation in Patients with BRAF-Mutated Metastatic Colorectal Cancer Treated with First-Line Bevacizumab and FOLFIRI.
- Published in:
- Journal of Oncology, 2021, p. 1, doi. 10.1155/2021/6686517
- By:
- Publication type:
- Article
Critical reappraisal of neoadjuvant concurrent chemoradiotherapy for treatment of locally advanced colon cancer.
- Published in:
- PLoS ONE, 2021, v. 16, n. 11, p. 1, doi. 10.1371/journal.pone.0259460
- By:
- Publication type:
- Article
Irinotecan dose reduction in metastatic colorectal cancer patients with homozygous UGT1A1*28 polymorphism: a single-center case series.
- Published in:
- Journal of International Medical Research, 2022, v. 50, n. 7, p. 1, doi. 10.1177/03000605221110697
- By:
- Publication type:
- Article
Time interval between the completion of radiotherapy and robotic-assisted surgery among patients with stage I–III rectal cancer undergoing preoperative chemoradiotherapy.
- Published in:
- PLoS ONE, 2020, v. 15, n. 10, p. 1, doi. 10.1371/journal.pone.0240742
- By:
- Publication type:
- Article
Unknown‑primary neuroendocrine neoplasms diagnosed by short‑acting somatostatin test: Case series in one institution.
- Published in:
- Experimental & Therapeutic Medicine, 2023, v. 25, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Clinicopathological Features and Oncological Outcomes of Early and Late Recurrence in Stage III Colorectal Cancer Patients after Adjuvant Oxaliplatin-Based Therapy.
- Published in:
- Journal of Oncology, 2023, p. 1, doi. 10.1155/2023/2439128
- By:
- Publication type:
- Article
Heterotopic intestine and abdominal wall transplantation in a miniature swine: A model for graft immunology.
- Published in:
- Kaohsiung Journal of Medical Sciences, 2023, v. 39, n. 11, p. 1129, doi. 10.1002/kjm2.12742
- By:
- Publication type:
- Article
Metformin Enhancement of Therapeutic Effects of 5-Fluorouracil and Oxaliplatin in Colon Cancer Cells and Nude Mice.
- Published in:
- Biomedicines, 2022, v. 10, n. 5, p. 955, doi. 10.3390/biomedicines10050955
- By:
- Publication type:
- Article
miRNA-148a Enhances the Treatment Response of Patients with Rectal Cancer to Chemoradiation and Promotes Apoptosis by Directly Targeting c-Met.
- Published in:
- Biomedicines, 2021, v. 9, n. 10, p. 1371, doi. 10.3390/biomedicines9101371
- By:
- Publication type:
- Article
Clinical Outcomes of Patients with Peritoneal Metastasis-Only Colorectal Cancer Treated with First-Line Bevacizumab and FOLFIRI Through Irinotecan Dose Escalation According to UGT1A1 Polymorphism: Compared to Liver Metastasis-Only, and Lung Metastasis-Only
- Published in:
- Cancer Management & Research, 2022, v. 14, p. 1541, doi. 10.2147/CMAR.S355318
- By:
- Publication type:
- Article
Is ypTNM staging a comparable predictor as pTNM staging for survival in non-metastatic rectal cancer after preoperative chemoradiation therapy?
- Published in:
- Oncology Research, 2024, v. 32, n. 11, p. 1723, doi. 10.32604/or.2024.052098
- By:
- Publication type:
- Article
Comparison of UGT1A1 Polymorphism as Guidance of Irinotecan Dose Escalation in RAS Wild-Type Metastatic Colorectal Cancer Patients Treated With Cetuximab or Bevacizumab Plus FOLFIRI as the First-Line Therapy.
- Published in:
- Oncology Research, 2021, v. 29, n. 1, p. 47, doi. 10.3727/096504022X16451187313084
- By:
- Publication type:
- Article
A Pilot Study of Silymarin as Supplementation to Reduce Toxicities in Metastatic Colorectal Cancer Patients Treated With First-Line FOLFIRI Plus Bevacizumab.
- Published in:
- Oncology Research, 2020, v. 28, n. 7/8, p. 801, doi. 10.3727/096504021X16218531628569
- By:
- Publication type:
- Article
Impact of previous abdominal surgery on robotic-assisted rectal surgery in patients with locally advanced rectal adenocarcinoma: a propensity score matching study.
- Published in:
- World Journal of Surgical Oncology, 2020, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12957-020-02086-1
- By:
- Publication type:
- Article
Iatrogenic pseudoaneurysm after bevacizumab therapy in patients with metastatic colorectal cancer: Two case reports.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Extended-Release Dinalbuphine Sebacate Versus Intravenous Patient-Controlled Analgesia with Fentanyl for Postoperative Moderate-to-Severe Pain: A Randomized Controlled Trial.
- Published in:
- Pain & Therapy, 2020, v. 9, n. 2, p. 671, doi. 10.1007/s40122-020-00197-x
- By:
- Publication type:
- Article
Effectiveness and Cost-Utility Analysis of Different Doses of Irinotecan Plus Bevacizumab in Patients With Metastatic Colorectal Cancer: A Long-Term and Prospective Cohort Study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.756078
- By:
- Publication type:
- Article
Real-World Outcomes of First-Line FOLFIRI Plus Bevacizumab with Irinotecan Dose Escalation versus FOLFOXIRI Plus Bevacizumab in BRAF V600E -Mutant Metastatic Colorectal Cancer: The Preliminary Data from a Single-Center Observational Study.
- Published in:
- Medicina (1010660X), 2023, v. 59, n. 12, p. 2108, doi. 10.3390/medicina59122108
- By:
- Publication type:
- Article
BRAF, MEK, and EGFR Triplet Inhibitors as Salvage Therapy in BRAF -Mutated Metastatic Colorectal Cancer—A Case Series Study Target Therapy of BRAF- Mutated mCRC.
- Published in:
- Medicina (1010660X), 2021, v. 57, n. 12, p. 1339, doi. 10.3390/medicina57121339
- By:
- Publication type:
- Article
Tests of linkage and heterogeneity in Mendelian diseases using identity by descent scores.
- Published in:
- Genetic Epidemiology, 1987, v. 4, n. 4, p. 255, doi. 10.1002/gepi.1370040404
- By:
- Publication type:
- Article
DNA Profile Similarity in a Subdivided Population.
- Published in:
- Human Heredity, 1994, v. 44, n. 2, p. 100, doi. 10.1159/000154199
- By:
- Publication type:
- Article
Oncological Outcomes of Robotic-Assisted Surgery With High Dissection and Selective Ligation Technique for Sigmoid Colon and Rectal Cancer.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.570376
- By:
- Publication type:
- Article